Septic shock patients were characterized by an increased IL-6 and IL-8, increased myeloid activation biomarkers, endothelial activation biomarkers (except TF), a prolonged coagulation, increased D-Dimers, and platelets activation biomarkers (Figures 5B–G). This evidence concerns the gene CXCL8 and septic shock.